New to Edison
Register today to access up-to-date company research.
Existing users
Log in to access company research.
Summer Internship programme
Vacancies currently open for:
- Earth Sciences
- Finance
- Accountancy
- Economics
- Marketing
- Business
Best Research Award 2007
Edison Investment Research, winners of 'Best Research Award'
ANGLE
| Date | Reports available | Download |
|---|---|---|
| Feb 14 2007 |
Excellent exit for cash Today’s annoucement of the acquisition of Acolyte Biomedica by 3M has the potential to be the largest trade sale cash exit in the UK IP commercialisation sector. Last month’s interim results reflect ANGLE’s increased outlays on developing its venture portfolio and its 20 year IP commercialisation agreement with the University of Reading (UoR). Important milestones have been reached, including positive interim clinical trial results and products launched by its Progeny® companies. Research type: Interim Review - Acquisition |
Log in to download 8 page note available |
| Jan 31 2007 |
Interim results Today’s interim results reflect ANGLE’s increased expenditure on developing its venture portfolio and its 20 year IP commercialisation agreement with the University of Reading (UoR). Important milestones have been reached, including positive clinical trial results and products launched by its Progeny companies. We are reviewing the statement and plan to issue a more detailed update shortly. Research type: Flash note - Interim results |
Log in to download 1 page note available |
| Nov 27 2006 |
Showcasing its IP portfolio and pipeline On 28 Nov 2006, ANGLE is showcasing its IP portfolio and development pipeline at The University of Reading (UoR), with whom the company signed a 20-year IP commercialisation agreement. With no news flow since the FY06 results and the UoR announcements in July, ANGLE’s share price has drifted. Research type: Quarterly update |
Log in to download 4 page note available |
| Aug 01 2006 |
Reading rapture The announcement of ANGLE’s first University IP commercialisation deal, a 20 year agreement with The University of Reading, is the jewel contained in the group’s preliminary results statement. During FY2006, ANGLE accelerated the development of its venture portfolio. Combined with its Consulting and Management (C&M) businesses, ANGLE now has an excellent three-pronged platform to realise significant capital generation. Research type: Outlook - Full year results |
Log in to download 12 page note available |
| Mar 08 2006 |
Ammunition loaded On 6 March, ANGLE announced a placing to develop its IP commercialisation portfolio. Both existing and new institutional shareholders have shown confidence in management by supporting a substantial 61% increase in the issued share capital of the company. The placing will raise £7.4m net proceeds, and is conditional on the approval of shareholders at an EGM on 29 March 2006. Research type: Update - Placing to raise £7.4m |
Log in to download 2 page note available |
| Jan 25 2006 |
Interims show progress Interim results Research type: Interim Review |
Log in to download 8 page note available |
| Oct 31 2005 |
Steady as she goes Update Research type: Quarterly Update |
Log in to download 4 page note available |
| Jul 25 2005 |
Continuing to build Interim Results Research type: Interim Review |
Log in to download 12 page note available |
| Mar 09 2005 |
Outlook Research type: Initiation of Coverage |
Log in to download 12 page note available |
- Register free to access the latest research.
- Contact us to find out how we help companies reach their investors.
IN THIS SECTION
Keep updated
Would you like to be notified when new research is published? Access our research RSS feed
Edison's research ... is balanced, objective and provides a level of detail not normally associated with smaller companies.
Peter Knowles
Director, Fyshe Horton Finney